Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2023 Earnings Conference Call February 28, 2024 5:00 PM ET

Company Participants

Paul Goodson – Investor Relations

Wenbin Jiang – Chief Executive Officer

Patrik Jeanmonod – Chief Financial Officer

Conference Call Participants

Matthew Sykes - Goldman Sachs

David Westenberg - Piper Sandler

Tejas Savant - Morgan Stanley

Steven Mah - TD Cowen

Mason Carrico - Stephens

Operator

Good day and thank you for standing by. Welcome to the Cytek Biosciences Fourth Quarter 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker for today, Paul Goodson, Head of Investor Relations. Please go ahead.

Paul Goodson

Thank you, operator. Earlier today, Cytek Biosciences released financial preliminary results for the quarter ended and year ended December 31st 2023. If you haven't received this news release, or if you'd like to be added to the company's distribution list, please send an email to investors@cytekbio.com. Joining me today from Cytek are Wenbin Jiang, Chief Executive Officer; and Patrik Jeanmonod, Chief Financial Officer.

Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of the Federal Securities laws, including statements regarding Cytek's business plans, strategies, opportunities, and financial projections. These statements are based on the company's current expectations and inherently involve significant risks and uncertainties that could cause actual results or events to materially differ from those anticipated. Additional information regarding these risks and uncertainties appears in the section entitled, Forward-Looking Statements in the press release Cytek issued today and in Cytek's SEC filings.

This call will also include a discussion of certain financial measures that are not calculated in accordance with generally accepted accounting principles. Reconciliation to the most directly comparable GAAP financial measure may be found in today's earnings release submitted to the SEC. Except as required by law, Cytek disclaims any duty to update any forward-looking statements whether because of new information, future events, or changes in its expectations. This conference call contains time-sensitive information and is accurate only as of the live broadcast, February 28th, 2024.

Finally, I would like to mention that Cytek will be participating in a variety of industry and academic conferences throughout 2024. While these are primarily geared to the scientific community, they may offer an opportunity to interact with users of our technologies to learn why Cytek's instruments are so highly valued by our customers.